Kapiva raises $60M in Sequence D spherical led by 360 ONE Asset and Vertex Progress

Kapiva, a healthcare model centered on Ayurveda-based merchandise, has raised $60 million in a Sequence D funding spherical.

The spherical included $28 million in main capital and was led by 360 ONE Asset and Vertex Progress, with participation from current buyers Vertex Ventures Southeast Asia and India and 3one4 Capital. The rest of the funds was used to supply exits to some early buyers.

Kapiva mentioned the funding might be used to broaden analysis and improvement, strengthen manufacturing, enhance model investments, and construct a health-tech platform aimed toward providing extra personalised care.

The corporate has reported greater than 80% annual development over the previous three years, with an annual income run fee of about 5.5 billion rupees ($66 million).

Its merchandise, which cowl classes akin to diabetes care, sports activities diet, liver perform, and common wellness, can be found via e-commerce platforms, its personal web site, and roughly 40,000 shops throughout India. Kapiva has additionally expanded into markets within the U.S., the Center East, and Europe.

Kapiva promoted its Chief Working Officer, Shantanu, and Chief Income Officer, Anuj Sharma, to the function of co-founders.

The corporate was established in 2016 by Ameve Sharma, a member of the Baidyanath Group household recognized for ayurvedic merchandise, and Shrey Badhani, a former guide at Bain & Co.

In 2023, Kapiva expanded into the US market via its wholly-owned subsidiary, Kapiva Inc. In 2021, Kapiva secured funding led by Vertex Ventures, with participation from Hearth Ventures, Jetty Ventures India, and Rishabh Mariwala. Earlier, in 2019, the corporate had raised $2.5 million in a funding spherical led by Hearth Ventures.

Avendus Capital suggested Kapiva and its shareholders on the transaction.